{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T05:05:04Z","timestamp":1763442304785,"version":"3.45.0"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:p>\n                    The objective of this endeavor was to analyze current evidence comparing tranexamic acid (TXA) with aminocaproic acid (EACA) to determine their relative efficacy and safety in adult patients undergoing cardiopulmonary bypass (CPB). A systematic review and meta-analysis were conducted utilizing the Preferred Reporting Items for Systematic Reviews and Meta-Analyses methodology to assess randomized controlled trials comparing TXA with EACA in adult CPB. Studies were excluded if not randomized, did not directly compare TXA with EACA, or did not involve the adult CPB population. The primary efficacy endpoint was total blood loss in 24 hours (mL). Safety endpoints included the most commonly reported adverse events. The secondary efficacy endpoint was total units of packed red blood cells transfused (units). Nine randomized controlled trials were included. TXA had a statistically significant reduction in 24-hour blood loss compared with EACA [\u22120.21 (CI, \u22120.36 to \u22120.06),\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    = 0.0070]. TXA also had a statistically significant reduction in total packed red blood cells infused [\u22120.30 (CI \u22120.50 to \u22120.11),\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    = 0.0025]. There was no significant difference in neurological [1.48 (0.92\u20132.38),\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    = 0.9843], renal [0.99 (0.85\u20131.15),\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    = 0.2274], cardiac [1.08 (0.88\u20131.32),\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    = 0.2068], or thrombotic [1.00 (0.39\u20132.58),\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    = 0.4450] events. With synthesized evidence supporting TXA, this review can help guide practitioners to make informed recommendations regarding periprocedural care to minimize blood loss and maximize resource use. This analysis and review supports the preferential use of TXA over EACA in adults undergoing CPB.\n                  <\/jats:p>","DOI":"10.1097\/crd.0000000000001130","type":"journal-article","created":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T05:00:16Z","timestamp":1763442016000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Comparison of the Efficacy and Safety of Tranexamic Acid Versus Aminocaproic Acid for Bleeding Prevention in Adult Surgical Patients Undergoing Cardiopulmonary Bypass: A Systematic Review and Meta-Analysis"],"prefix":"10.1097","author":[{"given":"Hunter A.","family":"Behrendt","sequence":"first","affiliation":[{"name":"Department of Pharmacy Practice, The University of Toledo College of Pharmacy and Pharmaceutical Sciences, Toledo, OH"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justin P.","family":"Reinert","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, The University of Toledo College of Pharmacy and Pharmaceutical Sciences, Toledo, OH"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,11,18]]},"reference":[{"key":"R1-20251118","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.atssr.2023.11.019","article-title":"Global cardiac surgical volume and gaps: trends, targets, and way forward.","volume":"2","author":"Vervoort","year":"2024","journal-title":"Ann Thorac Surg Short Rep"},{"key":"R2-20251118","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1051\/ject\/202254050","article-title":"Pulsatile perfusion during cardiopulmonary bypass: a literature review.","volume":"54","author":"Tan","year":"2022","journal-title":"J Extra Corpor Technol"},{"key":"R3-20251118","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1177\/1089253214530045","article-title":"A brief history of cardiopulmonary bypass.","volume":"18","author":"Hessel","year":"2014","journal-title":"Semin Cardiothorac Vasc Anesth"},{"key":"R4-20251118","doi-asserted-by":"crossref","first-page":"13","DOI":"10.36518\/2689-0216.1525","article-title":"Complications of cardiopulmonary bypass from an anesthesia perspective: a clinical review.","volume":"4","author":"Roberts","year":"2023","journal-title":"HCA Healthc J Med"},{"key":"R5-20251118","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1016\/S0003-4975(96)00937-X","article-title":"Treatment of excessive mediastinal bleeding after cardiopulmonary bypass.","volume":"62","author":"Hartstein","year":"1996","journal-title":"Ann Thorac Surg"},{"key":"R6-20251118","doi-asserted-by":"crossref","first-page":"760","DOI":"10.4103\/ija.IJA_379_17","article-title":"Basics of cardiopulmonary bypass.","volume":"61","author":"Sarkar","year":"2017","journal-title":"Indian J Anaesth"},{"key":"R7-20251118","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1053\/j.jvca.2020.08.033","article-title":"Individualized perioperative antifibrinolytic therapy: the next goal in cardiac surgery?","volume":"35","author":"Bolliger","year":"2021","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"R8-20251118","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1213\/ANE.0000000000004355","article-title":"Society of cardiovascular anesthesiologists clinical practice improvement advisory for management of perioperative bleeding and hemostasis in cardiac surgery patients.","volume":"129","author":"Raphael","year":"2019","journal-title":"Anesth Analg"},{"key":"R9-20251118","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1093\/ejcts\/ezx325","article-title":"2017 EACTS\/EACTA guidelines on patient blood management for adult cardiac surgery.","volume":"53","author":"Pagano","year":"2018","journal-title":"Eur J Cardiothorac Surg"},{"key":"R10-20251118","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1161\/CIR.0b013e31823b5fee","article-title":"2011 ACCF\/AHA guideline for coronary artery bypass graft surgery: executive summary.","volume":"124","author":"Hillis","year":"2011","journal-title":"Circulation"},{"key":"R11-20251118","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1001\/jamasurg.2019.1153","article-title":"Guidelines for perioperative care in cardiac surgery: Enhanced Recovery After Surgery Society recommendations.","volume":"154","author":"Engelman","year":"2019","journal-title":"JAMA Surg"},{"key":"R12-20251118","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.xjon.2020.05.011","article-title":"Commentary: epsilon-aminocaproic acid versus tranexamic acid, the David and Goliath of antifibrinolytics.","volume":"3","author":"Faraoni","year":"2020","journal-title":"JTCVS Open"},{"key":"R13-20251118","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.xjon.2020.05.003","article-title":"Comparison of intraoperative tranexamic acid and epsilon-aminocaproic acid in cardiopulmonary bypass patients.","volume":"3","author":"Broadwin","year":"2020","journal-title":"JTCVS Open"},{"key":"R14-20251118","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s12959-021-00303-9","article-title":"Tranexamic acid for the prevention and treatment of bleeding in surgery, trauma and bleeding disorders: a narrative review.","volume":"19","author":"Ockerman","year":"2021","journal-title":"Thromb J"},{"key":"R15-20251118","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/ana.24558","article-title":"Tranexamic acid-associated seizures: causes and treatment.","volume":"79","author":"Lecker","year":"2016","journal-title":"Ann Neurol"},{"key":"R16-20251118","doi-asserted-by":"crossref","first-page":"63","DOI":"10.5414\/CNP58063","article-title":"Epsilon-aminocaproic acid and renal complications: case report and review of the literature.","volume":"58","author":"Manjunath","year":"2002","journal-title":"Clin Nephrol"},{"key":"R17-20251118","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"R18-20251118","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials.","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"R19-20251118","doi-asserted-by":"crossref","first-page":"52","DOI":"10.4103\/jms.jms_149_21","article-title":"Comparison of effectiveness and safety of epsilon-aminocaproic acid and tranexamic acid in adult patients undergoing cardiac surgery.","volume":"36","author":"Singh","year":"2022","journal-title":"J Med Soc"},{"key":"R20-20251118","doi-asserted-by":"crossref","first-page":"265","DOI":"10.4103\/aca.ACA_137_18","article-title":"A randomized, double-blinded trial comparing the effectiveness of tranexamic acid and epsilon-aminocaproic acid in reducing bleeding and transfusion in cardiac surgery.","volume":"22","author":"Leff","year":"2019","journal-title":"Ann Card Anaesth"},{"key":"R21-20251118","doi-asserted-by":"crossref","first-page":"169","DOI":"10.24015\/JAPM.2018.0071","article-title":"Blood conservation using tranexamic acid versus epsilon aminocaproic acid in cardiac surgery: a randomized controlled trial.","volume":"5","author":"Gatling","year":"2018","journal-title":"J Anesth Periop Med"},{"key":"R22-20251118","doi-asserted-by":"crossref","first-page":"197","DOI":"10.15171\/jcvtr.2014.011","article-title":"Safety and efficacy of caproamin fides and tranexamic acid versus placebo in patients undergoing coronary artery revascularization.","volume":"6","author":"Alizadeh Ghavidel","year":"2014","journal-title":"J Cardiovasc Thorac Res"},{"key":"R23-20251118","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1053\/j.jvca.2013.04.003","article-title":"Comparison of epsilon aminocaproic acid and tranexamic acid in thoracic aortic surgery: clinical efficacy and safety.","volume":"27","author":"Makhija","year":"2013","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"R24-20251118","first-page":"45","article-title":"Blood conservation strategies for reducing perioperative blood loss in open heart surgery.","volume":"20","author":"Rahman","year":"2011","journal-title":"Mymensingh Med J"},{"key":"R25-20251118","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1056\/NEJMoa0802395","article-title":"A comparison of aprotinin and lysine analogues in high-risk cardiac surgery.","volume":"358","author":"Fergusson","year":"2008","journal-title":"N Engl J Med"},{"key":"R26-20251118","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1016\/S0003-4975(99)00866-8","article-title":"Hemostatic effects of aprotinin, tranexamic acid and epsilon-aminocaproic acid in primary cardiac surgery.","volume":"68","author":"Casati","year":"1999","journal-title":"Ann Thorac Surg"},{"key":"R27-20251118","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0003-4975(97)01016-3","article-title":"Prophylactic tranexamic acid and epsilon-aminocaproic acid for primary myocardial revascularization.","volume":"65","author":"Hardy","year":"1998","journal-title":"Ann Thorac Surg"},{"key":"R29-20251118","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1053\/j.jvca.2007.12.016","article-title":"A preliminary study of a new tranexamic acid dosing schedule for cardiac surgery.","volume":"22","author":"Nuttall","year":"2008","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"R30-20251118","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1097\/ALN.0b013e3182a443e8","article-title":"Comparison of two doses of tranexamic acid in adults undergoing cardiac surgery with cardiopulmonary bypass.","volume":"120","author":"Sigaut","year":"2014","journal-title":"Anesthesiology"},{"key":"R31-20251118","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1001\/jama.2022.10725","article-title":"Effect of high- vs low-dose tranexamic acid infusion on need for red blood cell transfusion and adverse events in patients undergoing cardiac surgery: the OPTIMAL randomized clinical trial.","volume":"328","author":"Shi","year":"2022","journal-title":"JAMA"},{"key":"R32-20251118","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.athoracsur.2012.04.057","article-title":"Incidence and risk factors of acute kidney injury after thoracic aortic surgery for acute dissection.","volume":"94","author":"Roh","year":"2012","journal-title":"Ann Thorac Surg"},{"key":"R33-20251118","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1053\/j.jvca.2010.10.007","article-title":"Seizures after open heart surgery: comparison of epsilon-aminocaproic acid and tranexamic acid.","volume":"25","author":"Martin","year":"2011","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"R34-20251118","doi-asserted-by":"crossref","first-page":"e210884","DOI":"10.1001\/jamasurg.2021.0884","article-title":"Association of intravenous tranexamic acid with thromboembolic events and mortality: a systematic review, meta-analysis, and meta-regression.","volume":"156","author":"Taeuber","year":"2021","journal-title":"JAMA Surg"}],"container-title":["Cardiology in Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CRD.0000000000001130","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T05:00:23Z","timestamp":1763442023000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CRD.0000000000001130"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,18]]},"references-count":33,"URL":"https:\/\/doi.org\/10.1097\/crd.0000000000001130","relation":{},"ISSN":["1538-4683"],"issn-type":[{"value":"1538-4683","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,18]]}}}